Subscribe To Our Free Newsletter |
Auro Pharma rises as arm’s facility clears USFDA inspection
Aurobindo Pharma added 1.23% to Rs 1,030.70 after the USFDA concluded its inspection at Telangana facility of the company's subsidiary with zero observations.